Our Impact
Effective mental health care needs innovative research that is embedded in the real world. On these pages you can explore the impact of the NIHR Maudsley Biomedical Research Centre and how we are making a difference to people’s lives, today and tomorrow.
Impact stories
1-4 of 4 impact stories
Point-of-care testing to enable patients to access clozapine
Experimental Medicine and Novel Therapeutics
New non-sedating drug treatment for anxiety disorders
Experimental Medicine and Novel Therapeutics
Psilocybin-assisted therapy for depression
Experimental Medicine and Novel Therapeutics
Using ketamine to test new drug therapies for schizophrenia
Experimental Medicine and Novel Therapeutics£50M
NIHR Funding Award (2022 - 2028)
The NIHR awarded the NIHR Maudsley BRC funding in 2022 to continue our work developing better and more targeted treatments in brain and mental health.